Log in or Sign up for Free to view tailored content for your specialty!
Regulatory/Legislative News
FDA warns of HORV risk with vancomycin intraocular injection
The FDA is warning against the use of prophylactic intraocular vancomycin formulations during cataract surgery because there is a risk for hemorrhagic occlusive retinal vasculitis.
Tom Price resigns as HHS secretary
Tom Price, MD, today offered his resignation as HHS secretary, according to a statement from the White House.
Log in or Sign up for Free to view tailored content for your specialty!
FDA accepts investigational new drug application for Ocugen’s dry eye treatment
The FDA has accepted an investigational new drug application for OCU310, a topical formulation for the treatment of dry eye disease, according to a press release from Ocugen.
WCO, Vision Impact Institute endorse Essilor, FIA road safety program
The World Council of Optometry and the Vision Impact Institute announced during the World Congress of Optometry in Hyderabad their endorsement of the Essilor and Fédération Internationale de l’Automobile partnership to promote the role of vision as a key pillar of road safety on a global scale through awareness-building campaigns.
BLOG: The importance of Medicaid
In revising the American health care system, it is critical to look at current delivery systems and determine what has worked and what has failed.
Five ophthalmology clinical trial updates you might have missed
Ophthalmic clinical trials of products for diabetic macular edema and Leber’s hereditary optic neuropathy, as well as geographic atrophy and pain and inflammation in cataract surgery, all moved forward in the month of August.
Don’t miss these 4 Healio blogs
Healio/Primary Care Optometry News bloggers address primary care and health reform, surgery and comanagement, clinical and diagnostic conundrums, and the implementation of social media in the optometric practice.
Usher syndrome candidate receives orphan drug designation
The FDA and the European Medicines Agency have granted orphan drug designation to QRX-421, an investigational drug for Usher syndrome, according to a press release from ProQR Therapeutics.
USPSTF recommends screening for lazy eye in children aged 3 to 5 years
The U.S. Preventive Services Task Force recommends that clinicians screen children for amblyopia or its risk factors at least once while the child is between 3 and 5 years of age, according to a report just released from JAMA.
BLOG: The case for primary care
In spite of the debate, drama and widespread awareness of the health care agenda in America, there has been no progress in resolving the most fundamental problem. This problem is the lack of resources for primary care services.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read